Housing
149297 Articles
[cnxvideo id=”513321″ placement=”ros”]Attempting to achieve stardom is a daunting task, especially when going for it alone. Imagine, though, having someone…
Wednesday was a mixed day for the broad U.S. markets. It’s possible that all three major indices would have notched…
MGIC Investment Group, Celldex Therapeutics, Juniper Networks, and Healthcare Services Group all posted new 52-week lows on Wednesday.
The Dow stocks were split between losers and winners Wednesday with IBM and J&J leading the losers while Home Depot…
The arrest of two black men in a Philadelphia Starbucks store last week went viral on social media virtually instantly…
It seems that things are only getting worse for Bed Bath & Beyond after Standard & Poor’s downgraded its credit…
Does Goldman Sachs want its Marcus brand to radically change its image, or does it want to keep the "Golden…
We shouldn’t expect another big tax charge this quarter, and that’s one reason to be optimistic. However, there are plenty…
IBM might have been fine if the company could only get investors to focus on revenues and earnings, but there…
U.S. petroleum inventories fell by modest amounts last week but the declines pushed crude oil prices to a high of…
Calithera Biosciences receives a Fast Track designation for its kidney cancer treatment, sending shares higher.
The April 2018 update to the IMF's World Economic Outlook includes some upbeat forecasts for near-term economic growth but warns…
Teligent watched its shares make a solid gain on Wednesday after the firm announced a key approval from the FDA.
Rigel Pharmaceuticals shares retreated early Wednesday despite an approval from the FDA for its treatment of thrombocytopenia.
With steel pricing firm, and export potential and demand at home still strong, all four of these stocks make sense…
Our top personal finance-related articles today. Your wallet will thank you later.